Results

Total Results: 621 records

Showing results for "hypertension".
Users also searched for: diabetes

241. Maternal Morbidity and Mortality (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
     February 02, 2022 - maternity units.22 For example, a woman’s likelihood of being screened for medical risk factors such as high … blood pressure, preeclampsia, diabetes, and substance misuse is affected by social factors such as … postpartum preeclampsia/eclampsia, and postpartum venous thrombosis), onset of new conditions (such as hypertension … postpartum preeclampsia/eclampsia, and postpartum venous thrombosis), onset of new conditions (such as hypertension … ● Prevalence of chronic disease ● Pre-pregnancy and pregnancy cardiovascular risk factors (hypertension

242. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - Diabetes, hypertension, and hyperlipidemia all also had strong observational evidence supporting associations … Gout is a "chronic" condition from the time of onset, similar to diabetes or hypertension. … As shown in trials of treat-to-target in diabetic lipids and hypertension, when it becomes an expectation … However, the evidence about lower levels altering the risk benefit ratio for diabetes and hypertension … Nonetheless, the concerns from diabetes and hypertension about lowering targets too low is not directly

243. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-illness-heart_research-protocol.pdf
     April 18, 2012 - interventions Nutrition interventions Weight-loss program Peer and family support interventions Hypertension … mortality) among adults with SMI who have cardiovascular disease, elevated cardiovascular risk (e.g., hypertension … • KQ 4: o Individuals who have CVD or elevated cardiovascular risk (e.g., hyperlipidemia, hypertension … levels KQ 4: • Individuals who have CVD or elevated cardiovascular risk (e.g., hyperlipidemia, hypertension … mortality) among adults with SMI who have cardiovascular disease, elevated cardiovascular risk (e.g., hypertension

244. Geographic Variation in Carotid Endarterectomy and Carotid Stenting Among Medicare Beneficiaries, 2003-2006 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cardiology-health-outcomes/research
     July 28, 2010 - -414.x, 429.2, and V45.81), dementia (codes 290.x, 294.1, and 331.2), diabetes mellitus (code 250), hypertension … 82.2) Dementia — 2092 (3.1) 293 (4.0) Diabetes mellitus — 25 395 (38.1) 3017 (41.0) Hypertension … (0.52-0.55) b 0.56 (0.50-0.62) b Diabetes mellitus 1.07 (1.05-1.08) b 1.07 (1.04-1.11) c Hypertension

245. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
     August 18, 2011 - management of many acute and chronic health problems, including diabetes, tuberculosis, HIV/AIDS, hypertension … greater frequency when the medications are used to treat asymptomatic, chronic conditions such as hypertension … disparities exist for many common chronic diseases, including cardiovascular disease, diabetes mellitus, hypertension … knowledge in 14 of the 16 studies reviewed, including studies that examined patient knowledge of diabetes, hypertension … A study of patients with hypertension and diabetes. Arch Intern Med 1998 Jan 26;158(2):166-72.

246. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - 38 reduced levels of ECG AFCL,33 the presence of hematoma,32 normal right-sided PV anatomy,29 hypertension … disease; TRI=temporal regularity index; SRI: spacial regularity index; CKD=chronic kidney disease; HTN=hypertension … TRI from baseline as a predictor of AF termination) OR=4.8, 95% CI: 1.0, 22.7 [MVA] (Absence of hypertension … factor against AF recurrence) Age (p=0.14), body mass index (p=0.93), duration of AF (p=0.32), hypertension … age: 60 yrs; Male: 79% PVI (n=71) NA AF recurrence (FU=60 mo) HR=2.9, 95% CI: 2.6, 3.1 (hypertension

247. Gout Dx protocol_140715-draft (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
     January 01, 2014 - paralleled the increase in prevalence of conditions associated with hyperuricemia, including obesity, hypertension … Patients with comorbidities including hypertension, type 2 diabetes, kidney disease (renal insufficiency … appropriate, sensitivity analysis will be conducted by age group and particular comorbidities, such as hypertension

248. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surge
     February 10, 2011 - Arthritis and nontraumatic joint disorders Cancer Cardiovascular disease, including stroke and hypertension

249. Renal-Artery-Stenosis Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
     June 01, 2012 - Signals Renal Artery Stenting Three independent predictors of BP response: 4) Requirement for ≥4 hypertension … Strategy: -------------------------------------------------------------------------------- 1 exp Hypertension … - Conclusions: Renal artery stenting initially improves hypertension control, but the durability

250. Effectiveness of Isosorbide Dinitrate and Hydralazine in Racial/Ethnic Subgroups With Heart Failure | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/congestive-heart-failure-medicines/research
     March 31, 2010 - No therapy, except hypertension control, has been shown to reduce mortality from diastolic HF. 20 , 21 … Cardiac arrhythmias 28.1% 24 <.0001 Peripheral vascular disorder 13.6% 20 <.0001 Hypertension … (uncomplicated) 73.7% 84 <.0001 Hypertension (complicated) 8.5% 18 <.0001 Diabetes (

251. Comparative Effectiveness Review No. 241_Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-241-physical-activity-wheelchair-evidence-summary-updated.pdf
     October 01, 2021 - on the prevention of cardiovascular conditions (e.g., myocardial infarction, stroke, development of hypertension

252. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_executive.pdf
     July 01, 2011 - Adverse clinical outcomes associated with OSA include: cardiovascular disease, hypertension, non-insulin-dependent … index, existing non-insulin-dependent diabetes mellitus, existing cardiovascular disease, existing hypertension … index, existing non-insulin-dependent diabetes mellitus, existing cardiovascular disease, existing hypertension … The two studies of cardiovascular mortality did not have consistent findings, and the two studies of hypertension … to (continued) uncertain conclusions regarding the possible association between AHI and incident hypertension

253. Hit-Patient-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hit-patient-care_executive.pdf
     June 01, 2012 - for enabling PCC for patients with clinical conditions other than diabetes mellitus, heart disease, hypertension … Second, more studies are needed on clinical conditions other than diabetes, hypertension, and heart

254. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - positive results n fecal occult blood test; class III/IV angina or uncontrolled CHF, uncontrolled hypertension … Low: ≤ 200 mg High: >20 mg Low: ≤ 25 mg High: > 25 mg Nonspecific NSAID NR New onset hypertension … One study of rofecoxib v diclofenac reported withdrawal due to CV events (hypertension: 3/231, palpitation … Other reported AEs include oedema (v diclofenac, RR 19.20 CIL 1.17, 314.55), hypertension (v diclofenac … Other discontinuations for hypertension (2/471 v 0/473; RR 5.02 CI: 0.24, 104.31) and oedema (3/471

255. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - pattern of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction, hypertension … Candesartan-based therapy and risk of cancer in patients with systemic hypertension (Heart Institute … of symptoms), dose of the ACE inhibitor or ARB used, comorbidities (diabetes, renal dysfunction, hypertension … of symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension … of symptoms), dose of the ACE inhibitor or ARB used, co-morbidities (diabetes, renal dysfunction, hypertension

256. S29 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
     October 01, 2007 - calcium-channel blockers, were widely believed to be a more effective initial therapy than thiazides for hypertension … as amlodipine, a calcium channel blocker, or lisinopril, an ACE inhibitor, for initial therapy for hypertension … vignettes, except that some subjects noted the existence of effective, relatively low cost treatments for hypertension

257. Allergy-Seasonal Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
     July 01, 2013 - Systemic adverse effects of decongestants may include hypertension, tachycardia, insomnia, headaches … used with caution, if at all, in patients with diabetes mellitus, ischemic heart disease, unstable hypertension … contraindicated with coadministered monoamine oxidase inhibitors and in patients with uncontrolled hypertension … pregnancy, in children, and in those whose treatment choices are restricted due to comorbidities, such as hypertension … Nosebleeds Nasal Discomfort Bitter Aftertaste Burning Anxiety Insomnia Palpitations Dryness Hypertension

258. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/clinician
     July 25, 2017 - of major adverse cardiac events (MACE), all-cause death, sudden cardiac death, revascularization, or high … blood pressure (BP). … conducted in populations at increased risk for CVD (e.g., with diabetes, cardiometabolic syndrome, hypertension

259. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
     July 01, 2017 - major adverse cardiac events (MACE), all-cause death, sudden cardiac death, revascularization, or high … blood pressure (BP). … conducted in populations at increased risk for CVD (e.g., with diabetes, cardiometabolic syndrome, hypertension

260. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/schedule-visits-antenatal-care/protocol
     August 06, 2021 - pregnant individuals at increased risk of poor outcomes (e.g., with gestational diabetes, gestational hypertension … complications: Maternal mortality Antenatal pregnancy complications Gestational diabetes Gestational hypertension … Exclusions listed for KQ 1 Telemedicine monitoring specifically for gestational diabetes, gestational hypertension … complications : maternal mortality, antenatal pregnancy complications (gestational diabetes, gestational hypertension